CAPT Conference Workshop: Defining “Decision Grade” Real World Evidence (RWE) and its Role in the Canadian Context: A Design Sprint On Sunday October 21, 2018, the Canadian Association of Population Therapeutics (CAPT) hosted a full day workshop to discuss recent advances in the dialogue on RWE in Canada from a Regulatory, HTA and Reimbursement perspective. The day was attended by participants invited from various stakeholder groups including Health Canada, … Read More →
Oncology
MORSE Consulting’s Managing Principal, Sherry O’Quinn, and Principal Consultant, Brad Alyward, are proud to participate in this year’s CADTH Symposium taking place from April 15-17, 2018 in Halifax, Nova Scotia. Further details on MORSE, and its strategic partner’s (Cornerstone Research Group) participation can be found below. April 16, 2018 15:15-16:30 ADT Sherry O’Quinn moderates a panel on oncology drugs with Alex Chambers (CADTH), Scott Gavura (CCO), Elena Lungu … Read More →
Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE LINKS, a new feature on our website. MORSE LINKS provides a comprehensive list of useful web links which can allow market access professionals to easily access frequently referenced web sites. Similar to other services offered by MORSE, LINKS has a user-friendly interface with information separated into broad categories to allow users to sort and search based … Read More →
MORSE Consulting Inc. | Deciphering pharmaceutical market access signals to create reimbursement success.
© 2019 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
Oncology Archives - MORSE Consulting Inc.
